NGL Fine-Chem FY26 Profit Rises 128%; Revenue Grows 36%
NGL Fine-Chem Limited reported a 128% YoY increase in FY26 net profit to Rs. 4,813 lakh, with revenue growing 36% to Rs. 50,095 lakh. Q4 performance was strong, with revenue rising 57% to Rs. 149.23 crore and EBITDA margins expanding significantly to 14.35%. The board recommended a final dividend of Rs. 1.75 per share and scheduled the AGM for August 25, 2026.
*this image is generated using AI for illustrative purposes only.
NGL Fine-Chem Limited has reported its audited financial results for the quarter and year ended March 31, 2026. The company's consolidated net profit for the year surged to Rs. 4,813 lakh, a significant increase of 128% from Rs. 2,112 lakh in the previous year. Revenue from operations for the year stood at Rs. 50,095 lakh compared to Rs. 36,826 lakh in FY25. The board has recommended a final dividend of Rs. 1.75 per share.
Financial Performance
For the quarter ended March 31, 2026, NGL Fine-Chem delivered a strong operational performance, with Q4 revenue rising 57% year-on-year to Rs. 149.23 crore. This growth was driven entirely by volume expansion, marking the third consecutive quarter of robust volume growth. Q4 EBITDA increased to Rs. 21.41 crore from Rs. 6.32 crore in the same period last year. The EBITDA margin expanded to 14.35% from 6.65% year-on-year. Consolidated net profit for the quarter came in at Rs. 13.49 crore, compared to Rs. 0.54 crore in the corresponding quarter of the previous year.
The following table summarises the key consolidated financial metrics for the full year and the quarter:
| Metric: | FY26 | FY25 | Change (YoY) |
|---|---|---|---|
| Revenue from Operations | Rs. 50,095 lakh | Rs. 36,826 lakh | +36% |
| Net Profit | Rs. 4,813 lakh | Rs. 2,112 lakh | +128% |
| EPS (Basic) | Rs. 77.90 | Rs. 34.19 | Higher |
| Metric: | Q4 FY26 | Q4 FY25 |
|---|---|---|
| Revenue | Rs. 149.23 crore | Rs. 94.97 crore |
| EBITDA | Rs. 21.41 crore | Rs. 6.32 crore |
| EBITDA Margin | 14.35% | 6.65% |
| Net Profit | Rs. 13.49 crore | Rs. 0.54 crore |
Operational Highlights
The company reported that Animal API segment revenue constituted 95% of the total mix in Q4FY26. Geographically, Asia accounted for 43% of the revenue, followed by India at 23% and Rest of the World at 26%. Management noted that while geopolitical volatility increased freight and raw material costs, partial price pass-through was achieved in the first quarter. Phase I of the capex programme is contributing to operations, while Phase II commissioning is now scheduled for early Q2FY27.
Key Meeting Decisions
The board has scheduled the 45th Annual General Meeting (AGM) for Tuesday, August 25, 2026, via Video Conferencing. The record date for determining eligibility for the AGM and dividend payment is Tuesday, August 18, 2026. The register of members and share transfer books will remain closed from Wednesday, August 19, 2026, to Tuesday, August 25, 2026. Additionally, the board approved the reappointment of Mr. Rajesh Lawande as Whole-Time Director and Mrs. Sarala Menon as Independent Director, subject to shareholder approval.
Historical Stock Returns for NGL Fine Chem
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +9.35% | +20.43% | +21.16% | +102.95% | +112.80% | +46.38% |
How will the commissioning of Phase II capex in early Q2FY27 impact NGL Fine-Chem's production capacity and revenue trajectory for FY27?
Given that Animal API constitutes 95% of revenue, what risks does this concentration pose if regulatory changes or disease outbreaks affect the veterinary pharmaceutical market?
With geopolitical volatility already pressuring freight and raw material costs, how sustainable are the current EBITDA margins if full price pass-through cannot be achieved in subsequent quarters?
15
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
